BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest. 1966;45:645-657. [PMID: 5327481 DOI: 10.1172/jci105380] [Cited by in Crossref: 558] [Cited by in F6Publishing: 88] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Sweetlove MA, Lötter MG, Roodt JP, Badenhorst PN, Kotzé HF, Heyns AD. Blood platelet kinetics in normal subjects modelled by compartmental analysis. Eur J Nucl Med 1992;19:1023-31. [PMID: 1464354 DOI: 10.1007/BF00180863] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Moser G, Guettler J, Forstner D, Gauster M. Maternal Platelets—Friend or Foe of the Human Placenta? Int J Mol Sci 2019;20:E5639. [PMID: 31718032 DOI: 10.3390/ijms20225639] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Sheikh MY, Raoufi R, Atla PR, Riaz M, Oberer C, Moffett MJ. Prevalence of cirrhosis in patients with thrombocytopenia who receive bone marrow biopsy. Saudi J Gastroenterol 2012;18:257-62. [PMID: 22824769 DOI: 10.4103/1319-3767.98431] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
4 Lin KH, Hsu PI, Yu HC, Lin CK, Tsai WL, Chen WC, Chan HH, Lai KH. Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts. BMC Gastroenterol 2012;12:7. [PMID: 22257364 DOI: 10.1186/1471-230X-12-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
5 Scharf RE, Schneider W, Heisig S, Schramm W. [Thrombocytopenia in liver cirrhosis]. Klin Wochenschr 1983;61:703-8. [PMID: 6887759 DOI: 10.1007/BF01487616] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Aerts JM, Donker-Koopman WE, Brul S, Van Weely S, Sa Miranda MC, Barranger JA, Tager JM, Schram AW. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease. Biochem J 1990;269:93-100. [PMID: 2198026 DOI: 10.1042/bj2690093] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
7 Rauber P, Lammert F, Grotemeyer K, Appenrodt B. Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study. PLoS One 2018;13:e0192271. [PMID: 29438423 DOI: 10.1371/journal.pone.0192271] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
8 Matsukiyo Y, Nagai H, Matsui T, Igarashi Y. Host Immunological Effects of Partial Splenic Embolization in Patients with Liver Cirrhosis. J Immunol Res 2018;2018:1746391. [PMID: 30116748 DOI: 10.1155/2018/1746391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
9 Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World J Gastroenterol 2017;23:3228-39. [PMID: 28566882 DOI: 10.3748/wjg.v23.i18.3228] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
10 Lee S, Park SJ, Cheon JH, Kim TI, Kim WH, Kang DR, Hong SP. Child-Pugh score is an independent risk factor for immediate bleeding after colonoscopic polypectomy in liver cirrhosis. Yonsei Med J 2014;55:1281-8. [PMID: 25048486 DOI: 10.3349/ymj.2014.55.5.1281] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
11 Keatinge WR, Coleshaw SR, Cotter F, Mattock M, Murphy M, Chelliah R. Increases in platelet and red cell counts, blood viscosity, and arterial pressure during mild surface cooling: factors in mortality from coronary and cerebral thrombosis in winter. Br Med J (Clin Res Ed) 1984;289:1405-8. [PMID: 6437575 DOI: 10.1136/bmj.289.6456.1405] [Cited by in Crossref: 380] [Cited by in F6Publishing: 292] [Article Influence: 10.6] [Reference Citation Analysis]
12 Belizaire R, Makar RS. Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion. Transfus Med Rev 2020;34:242-9. [PMID: 33129606 DOI: 10.1016/j.tmrv.2020.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Saab S, Brown RS Jr. Management of Thrombocytopenia in Patients with Chronic Liver Disease. Dig Dis Sci. 2019;64:2757-2768. [PMID: 31011942 DOI: 10.1007/s10620-019-05615-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
14 Mitchell O, Feldman DM, Diakow M, Sigal SH. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016;8:39-50. [PMID: 27186144 DOI: 10.2147/hmer.s74612] [Cited by in Crossref: 18] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
15 Yonal I, Pinarbası B, Hindilerden F, Hancer VS, Nalcaci M, Kaymakoglu S, Diz-Kucukkaya R. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. J Thromb Thrombolysis 2012;34:388-96. [PMID: 22569900 DOI: 10.1007/s11239-012-0738-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Assinger A. Platelets and infection - an emerging role of platelets in viral infection. Front Immunol 2014;5:649. [PMID: 25566260 DOI: 10.3389/fimmu.2014.00649] [Cited by in Crossref: 161] [Cited by in F6Publishing: 133] [Article Influence: 23.0] [Reference Citation Analysis]
17 Li Y, Ryan J, Xu F, Vostal JG. Macrophage Depletion Mitigates Platelet Aggregate Formation in Splenic Marginal Zone and Alleviates LPS-Associated Thrombocytopenia in Rats. Front Med (Lausanne) 2019;6:300. [PMID: 31921873 DOI: 10.3389/fmed.2019.00300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Shimizu R, Katsube T, Wajima T. Quantitative systems pharmacology model of thrombopoiesis and platelet life-cycle, and its application to thrombocytopenia based on chronic liver disease. CPT Pharmacometrics Syst Pharmacol 2021;10:489-99. [PMID: 33797208 DOI: 10.1002/psp4.12623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Schiavon Lde L, Narciso-Schiavon JL, de Carvalho-Filho RJ. Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol. 2014;20:2854-2866. [PMID: 24659877 DOI: 10.3748/wjg.v20.i11.2854] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
20 Bassendine MF, Collins JD, Stephenson J, Saunders P, James OF. Platelet associated immunoglobulins in primary biliary cirrhosis: a cause of thrombocytopenia? Gut 1985;26:1074-9. [PMID: 4054707 DOI: 10.1136/gut.26.10.1074] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
21 Reese JA, Peck JD, Yu Z, Scordino TA, Deschamps DR, McIntosh JJ, Terrell DR, Vesely SK, George JN. Platelet sequestration and consumption in the placental intervillous space contribute to lower platelet counts during pregnancy. Am J Hematol 2019;94:E8-E11. [PMID: 30328633 DOI: 10.1002/ajh.25321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
22 Hashimoto N, Shimoda S, Kawanaka H, Tsuneyama K, Uehara H, Akahoshi T, Kinjo N, Taketomi A, Shirabe K, Akashi K. Modulation of CD4+ T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis. Clin Exp Immunol. 2011;165:243-250. [PMID: 21615390 DOI: 10.1111/j.1365-2249.2011.04393.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
23 Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46:S2-S14. [PMID: 19245930 DOI: 10.1053/j.seminhematol.2008.12.005] [Cited by in Crossref: 117] [Cited by in F6Publishing: 87] [Article Influence: 9.8] [Reference Citation Analysis]
24 Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H. Management of thrombocytopenia due to liver cirrhosis: a review. World J Gastroenterol. 2014;20:2595-2605. [PMID: 24627595 DOI: 10.3748/wjg.v20.i10.2595] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 51] [Article Influence: 9.5] [Reference Citation Analysis]
25 Kee KM, Wang JH, Hung CH, Chen CH, Lee CM, Lu SN. Improvement of thrombocytopenia in hepatitis C-related advanced fibrosis patients after sustained virological response. Dig Dis Sci 2013;58:556-61. [PMID: 23001404 DOI: 10.1007/s10620-012-2380-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
26 Zeng DW, Liu YR, Zhang JM, Zhu YY, Lin S, You J, Li YB, Chen J, Zheng Q, Jiang JJ, Dong J. Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease. PLoS One. 2013;8:e77942. [PMID: 24282481 DOI: 10.1371/journal.pone.0077942] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
27 Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics. 2009;8:986-994. [PMID: 19181623 DOI: 10.1074/mcp.M800470-MCP20042] [Reference Citation Analysis]
28 Shao LN, Zhang ST, Wang N, Yu WJ, Chen M, Xiao N, Duan Y, Pan LZ, Song WQ, Xia YX, Zhang L, Qi N, Liu M, Zhou SH. Platelet indices significantly correlate with liver fibrosis in HCV-infected patients. PLoS One. 2020;15:e0227544. [PMID: 31917827 DOI: 10.1371/journal.pone.0227544] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
29 Karasu Z, Gurakar A, Kerwin B, Hulagu S, Jazzar A, McFadden R, Nour B, Sebastian A, Cassidy F, Stokes K, Van Thiel DH, Wright H. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci. 2000;45:1971-1976. [PMID: 11117569 DOI: 10.1023/a:1005694617983] [Cited by in Crossref: 28] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
30 Hermos JA, Altincatal A, Weber HC, Grotzinger K, Smoot KJ, Cho K, Gagnon DR, Lawler EV. Thrombocytopenia and bleeding in veterans with non-hepatitis C-related chronic liver disease. Dig Dis Sci 2013;58:562-73. [PMID: 23010745 DOI: 10.1007/s10620-012-2404-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
31 Lv Y, Lau WY, Li Y, Deng J, Han X, Gong X, Liu N, Wu H. Hypersplenism: History and current status. Exp Ther Med 2016;12:2377-82. [PMID: 27703501 DOI: 10.3892/etm.2016.3683] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
32 Wessels P, Heyns AD, Pieters H, Lötter MG, Badenhorst PN. An improved method for the quantification of the in vivo kinetics of a representative population of 111In-labelled human platelets. Eur J Nucl Med 1985;10:522-7. [PMID: 3928383 DOI: 10.1007/BF00252745] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Fujii H, Enomoto M, Fukushima W, Ohfuji S, Mori M, Kobayashi S, Iwai S, Morikawa H, Tamori A, Sakaguchi H, Ikura Y, Ueda M, Kawada N. Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis. J Gastroenterol 2009;44:608-14. [PMID: 19360373 DOI: 10.1007/s00535-009-0046-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
34 Wang J, Yan X, Yang Y, Chang H, Jia B, Zhao XA, Chen G, Xia J, Liu Y, Chen Y, Wang G, Wang L, Zhang Z, Ding W, Huang R, Wu C. A novel predictive model using routinely clinical parameters to predict liver fibrosis in patients with chronic hepatitis B. Oncotarget. 2017;8:59257-59267. [PMID: 28938634 DOI: 10.18632/oncotarget.19501] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
35 Zeng X, Xu C, He D, Li M, Zhang H, Wu Q, Xiang D, Wang Y. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B. Croat Med J. 2015;56:272-279. [PMID: 26088852 DOI: 10.3325/cmj.2015.56.272] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
36 Smellie WS, Forth J, Bareford D, Twomey P, Galloway MJ, Logan EC, Smart SR, Reynolds TM, Waine C. Best practice in primary care pathology: review 3. J Clin Pathol 2006;59:781-9. [PMID: 16873560 DOI: 10.1136/jcp.200X.033944] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
37 Toy JL, Lederer DA, Tulpule AT, Tandon AP, Taylor SH, McNicol GP. Coagulation studies in rheumatic heart disease. Br Heart J 1980;43:301-5. [PMID: 6776971 DOI: 10.1136/hrt.43.3.301] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
38 Mai RY, Zeng J, Mo YS, Liang R, Lin Y, Wu SS, Piao XM, Gao X, Wu GB, Li LQ, Ye JZ. Artificial Neural Network Model for Liver Cirrhosis Diagnosis in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma. Ther Clin Risk Manag 2020;16:639-49. [PMID: 32764948 DOI: 10.2147/TCRM.S257218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Thakrar SV, Mallett SV. Thrombocytopenia in cirrhosis: Impact of fibrinogen on bleeding risk. World J Hepatol 2017;9:318-25. [PMID: 28293381 DOI: 10.4254/wjh.v9.i6.318] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
40 Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, Vesely SK, George JN. Platelet Counts during Pregnancy. N Engl J Med 2018;379:32-43. [PMID: 29972751 DOI: 10.1056/NEJMoa1802897] [Cited by in Crossref: 58] [Cited by in F6Publishing: 6] [Article Influence: 19.3] [Reference Citation Analysis]
41 Ko S, Chisuwa H, Matsumoto M, Fujimura Y, Okano E, Nakajima Y. Relevance of ADAMTS13 to liver transplantation and surgery. World J Hepatol 2015;7:1772-81. [PMID: 26167250 DOI: 10.4254/wjh.v7.i13.1772] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
42 Izak M, Bussel JB. Management of thrombocytopenia. F1000Prime Rep. 2014;6:45. [PMID: 24991422 DOI: 10.12703/p6-45] [Cited by in Crossref: 47] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
43 Söhngen D, Schneider W. [Thrombocyte transfusion: clinical aspects, follow-up and complications]. Klin Wochenschr 1991;69:379-86. [PMID: 1921239 DOI: 10.1007/BF01647409] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
44 Yoneda M, Fujii H, Sumida Y, Hyogo H, Itoh Y, Ono M, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Imajo K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease. Platelet count for predicting fibrosis in nonalcoholic fatty liver disease. J Gastroenterol. 2011;46:1300-1306. [PMID: 21750883 DOI: 10.1007/s00535-011-0436-4] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 6.6] [Reference Citation Analysis]
45 Ho SY, Liu PH, Hsu CY, Hsia CY, Su CW, He YJ, Lee YH, Huang YH, Hou MC, Huo TI. Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma. Sci Rep 2018;8:15074. [PMID: 30305679 DOI: 10.1038/s41598-018-33536-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
46 Hanafy AS, El Hawary AT, Hamed EF, Hassaneen AM. Impact of Helicobacter pylori eradication on refractory thrombocytopenia in patients with chronic HCV awaiting antiviral therapy. Eur J Clin Microbiol Infect Dis 2016;35:1171-6. [PMID: 27180243 DOI: 10.1007/s10096-016-2650-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
47 Mao W, Sun Q, Fan J, Lin S, Ye B. AST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis. Medicine (Baltimore) 2016;95:e2946. [PMID: 26945406 DOI: 10.1097/MD.0000000000002946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
48 Maan R, de Knegt RJ, Veldt BJ. Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies. Drugs 2015;75:1981-92. [PMID: 26501978 DOI: 10.1007/s40265-015-0480-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
49 Sweetlove MA, Lötter MG, Roodt JP, Badenhorst PN, Kotzé HF, Heyns AD. Blood platelet kinetics in normal subjects modelled by compartmental analysis. Eur J Nucl Med. 1992;19:1023-1031. [PMID: 1464354 DOI: 10.1016/j.eurpsy.2003.06.006] [Cited by in Crossref: 75] [Cited by in F6Publishing: 54] [Article Influence: 2.7] [Reference Citation Analysis]
50 Stasi R, Chia LW, Kalkur P, Lowe R, Shannon MS. Pathobiology and treatment of hepatitis virus-related thrombocytopenia. Mediterr J Hematol Infect Dis 2009;1:e2009023. [PMID: 21415958 DOI: 10.4084/MJHID.2009.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
51 Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, Burroughs AK. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut. 1999;44:754-758. [PMID: 10205219 DOI: 10.1136/gut.44.5.754] [Cited by in Crossref: 101] [Cited by in F6Publishing: 86] [Article Influence: 4.6] [Reference Citation Analysis]
52 Sekiguchi T, Nagamine T, Takagi H, Mori M. Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol 2006;12:1205-10. [PMID: 16534872 DOI: 10.3748/wjg.v12.i8.1205] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
53 Habibi A, Esfandbod M, Ghafari MH, Khashayar P, Najafi A, Moharari RS. Platelet kinetics after slow versus standard transfusions: a pilot study. Ups J Med Sci 2011;116:212-5. [PMID: 21679106 DOI: 10.3109/03009734.2011.569588] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Aster RH. Blood platelet kinetics and platelet transfusion. J Clin Invest 2013;123:4564-5. [PMID: 24177466 DOI: 10.1172/JCI70335] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
55 Qamar AA, Grace ND. Abnormal hematological indices in cirrhosis. Can J Gastroenterol 2009;23:441-5. [PMID: 19543577 DOI: 10.1155/2009/591317] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
56 Skudowitz RB, Katz J, Lurie A, Levin J, Metz J. Mechanisms of thrombocytopenia in malignant tertian malaria. Br Med J 1973;2:515-8. [PMID: 4714466 DOI: 10.1136/bmj.2.5865.515] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 1.5] [Reference Citation Analysis]
57 Kim NH, Kim HJ, Cho YK, Hong HP, Kim BI. Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization. J Korean Med Sci 2019;34:e208. [PMID: 31373186 DOI: 10.3346/jkms.2019.34.e208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Liu L, Cao J, Zhong Z, Guo Z, Jiang Y, Bai Y, Xu J. Noninvasive indicators predict advanced liver fibrosis in autoimmune hepatitis patients. J Clin Lab Anal 2019;33:e22922. [PMID: 31115929 DOI: 10.1002/jcla.22922] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
59 Feld JJ, Hussain N, Wright EC, Kleiner DE, Hoofnagle JH, Ahlawat S, Anderson V, Hilligoss D, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology 2008;134:1917-26. [PMID: 18439425 DOI: 10.1053/j.gastro.2008.02.081] [Cited by in Crossref: 63] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
60 Nwokediuko SC, Ibegbulam O. Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease. Gastroenterology Res 2009;2:344-9. [PMID: 27990204 DOI: 10.4021/gr2009.12.1329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
61 Tejima K, Masuzaki R, Ikeda H, Yoshida H, Tateishi R, Sugioka Y, Kume Y, Okano T, Iwai T, Gotoh H. Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly. J Gastroenterol. 2010;45:876-884. [PMID: 20339877 DOI: 10.1007/s00535-010-0233-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
62 Oh Y, Yoo SY, Choi GS, Kim G. Liver transplantation of a patient with extreme thrombocytopenia - A case report. Anesth Pain Med (Seoul) 2021;16:279-83. [PMID: 34233411 DOI: 10.17085/apm.21006] [Reference Citation Analysis]
63 Tytgat GN, Collen D, Verstraete M. Metabolism of fibrinogen in cirrhosis of the liver. J Clin Invest 1971;50:1690-701. [PMID: 5163179 DOI: 10.1172/JCI106658] [Cited by in Crossref: 81] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
64 Crespillo-Andújar C, Calbacho Robles M, Norman FF, Pérez-Molina JA. Severe immune thrombocytopaenia in a patient taking benznidazole for chronic Chagas disease. BMJ Case Rep 2018;2018:bcr-2017-223788. [PMID: 29588298 DOI: 10.1136/bcr-2017-223788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
65 Konkle BA. Percutaneous interventions in the coagulopathic patient. Semin Intervent Radiol 2005;22:88-94. [PMID: 21326678 DOI: 10.1055/s-2005-871863] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
66 Blendis LM. Hypersplenism in cirrhosis. Postgrad Med J 1969;45:223-6. [PMID: 5785434 DOI: 10.1136/pgmj.45.521.223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
67 Poddar U, Shava U, Yachha SK, Agarwal J, Kumar S, Baijal SS, Srivastava A. β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children. Hepatol Int 2015;9:447-53. [PMID: 25788181 DOI: 10.1007/s12072-014-9575-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
68 Kondo R, Yano H, Nakashima O, Tanikawa K, Nomura Y, Kage M. Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C. J Gastroenterol. 2013;48:526-534. [PMID: 22911171 DOI: 10.1007/s00535-012-0656-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
69 Cheng KC, Lin WY, Liu CS, Lin CC, Lai HC, Lai SW. Association of different types of liver disease with demographic and clinical factors. Biomedicine (Taipei) 2016;6:16. [PMID: 27518399 DOI: 10.7603/s40681-016-0016-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
70 Verma V, Sarin SK, Sharma P, Kumar A. Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosis. United European Gastroenterol J 2014;2:226-31. [PMID: 25360306 DOI: 10.1177/2050640614527084] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
71 Lambert MP. Platelets in liver and renal disease. Hematology Am Soc Hematol Educ Program. 2016;2016:251-255. [PMID: 27913488 DOI: 10.1182/asheducation-2016.1.251] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
72 Rawi S, Wu GY. Pathogenesis of Thrombocytopenia in Chronic HCV Infection: A Review. J Clin Transl Hepatol 2020;8:184-91. [PMID: 32832399 DOI: 10.14218/JCTH.2020.00007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
73 Finsterbusch M, Schrottmaier WC, Kral-Pointner JB, Salzmann M, Assinger A. Measuring and interpreting platelet-leukocyte aggregates. Platelets 2018;29:677-85. [PMID: 29461910 DOI: 10.1080/09537104.2018.1430358] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 14.7] [Reference Citation Analysis]
74 Qureshi K, Patel S, Meillier A. The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence. Int J Hepatol 2016;2016:1802932. [PMID: 27800187 DOI: 10.1155/2016/1802932] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
75 Kenny MW, George AJ, Stuart J. Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism. J Clin Pathol 1980;33:622-5. [PMID: 7430367 DOI: 10.1136/jcp.33.7.622] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 1.4] [Reference Citation Analysis]
76 Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H. Pivotal role of ADAMTS13 function in liver diseases. Int J Hematol. 2010;91:20-29. [PMID: 20054668 DOI: 10.1007/s12185-009-0481-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
77 Tahara H, Takagi H, Sato K, Shimada Y, Tojima H, Hirokawa T, Ohyama T, Horiuchi K, Naganuma A, Arai H. A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia. J Gastroenterol. 2011;46:1010-1019. [PMID: 21594564 DOI: 10.1007/s00535-011-0407-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
78 Yoshida M, Shiraishi S, Sakaguchi F, Utsunomiya D, Tashiro K, Tomiguchi S, Okabe H, Beppu T, Baba H, Yamashita Y. A quantitative index measured on ⁹⁹mTc GSA SPECT/CT 3D fused images to evaluate severe fibrosis in patients with chronic liver disease. Jpn J Radiol 2012;30:435-41. [PMID: 22492469 DOI: 10.1007/s11604-012-0072-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
79 Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest 1969;48:963-74. [PMID: 5814231 DOI: 10.1172/JCI106077] [Cited by in Crossref: 442] [Cited by in F6Publishing: 45] [Article Influence: 8.5] [Reference Citation Analysis]
80 Pohjonen HK, Savolainen SE, Nikkinen PH, Poutanen VP, Korppi-Tommola ET, Liewendahl BK. Abdominal SPECT/MRI fusion applied to the study of splenic and hepatic uptake of radiolabeled thrombocytes and colloids. Ann Nucl Med 1996;10:409-17. [PMID: 9006726 DOI: 10.1007/BF03164802] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
81 Chen YC, Tseng CW, Tseng KC. Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents. Medicine (Baltimore) 2020;99:e20156. [PMID: 32384505 DOI: 10.1097/MD.0000000000020156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Grassi G, Lenci I, Signorello A, Milana M, Baiocchi L. Gastrointestinal endoscopy in cirrhotic patient: Issues on the table. World J Gastrointest Endosc 2021;13:210-20. [PMID: 34326942 DOI: 10.4253/wjge.v13.i7.210] [Reference Citation Analysis]
83 Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H. Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis. Int J Hepatol 2011;2011:759047. [PMID: 21994870 DOI: 10.4061/2011/759047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
84 Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics. 2009;8:986-994. [PMID: 19181623 DOI: 10.1074/mcp.m800470-mcp200] [Cited by in Crossref: 89] [Cited by in F6Publishing: 39] [Article Influence: 7.4] [Reference Citation Analysis]
85 Ahmad W, Ijaz B, Gull S, Asad S, Khaliq S, Jahan S, Sarwar MT, Kausar H, Sumrin A, Shahid I. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Virol J. 2011;8:53. [PMID: 21299910 DOI: 10.1186/1743-422x-8-53] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
86 Ceylan B, Mete B, Fincanci M, Aslan T, Akkoyunlu Y, Ozguneş N, Colak O, Gunduz A, Senates E, Ozaras R. A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection. Wien Klin Wochenschr. 2013;125:453-460. [PMID: 23860694 DOI: 10.1007/s00508-013-0394-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
87 Wu Y, Tu C, Shao C. Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy. BMC Surg 2021;21:178. [PMID: 33794850 DOI: 10.1186/s12893-021-01180-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Han X, Lv Y, Li Y, Deng J, Qiu Q, Liu N, Zhao S, Liao C. Distribution characteristics of cells in splenomegaly due to hepatitis B-related cirrhotic portal hypertension and their clinical importance. J Int Med Res 2018;46:2633-40. [PMID: 29781346 DOI: 10.1177/0300060518767550] [Reference Citation Analysis]